Xiang Yang Lu
Directeur Général chez LAEKNA, INC.
Fortune : 43 M $ au 31/05/2024
Postes actifs de Xiang Yang Lu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LAEKNA, INC. | Directeur Général | 29/07/2016 | - |
| Président | 29/07/2016 | - | |
| Fondateur | 29/07/2016 | - | |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | - | - |
| Directeur Général | 01/12/2016 | - | |
| Fondateur | 01/12/2016 | - | |
| Laekna Ltd. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Xiang Yang Lu
Anciens postes connus de Xiang Yang Lu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| China Novartis Institutes for BioMedical Research Co., Ltd. | Directeur/Membre du Conseil | 01/09/2003 | 01/03/2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/09/2003 | 01/03/2016 |
| Frontline Bioventures | Corporate Officer/Principal | 01/01/2016 | - |
Formation de Xiang Yang Lu
| Nankai University | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Statistiques
Internationale
| Chine | 5 |
| Etats-Unis | 3 |
| Îles Cayman | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LAEKNA, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Health Technology |
| Frontline Bioventures | Finance |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Laekna Ltd. | |
| China Novartis Institutes for BioMedical Research Co., Ltd. |
- Bourse
- Insiders
- Xiang Yang Lu
- Expérience
